Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Epistaxis, or acute ...

SAN DIEGO -- In a randomized trial, pomalidomide (Pomalyst) significantly reduced severe nosebleeds in patients with hereditary hemorrhagic telangiectasia (HHT), a condition with no approved therapy.

Hereditary hemorrhagic telangiectasia (HHT) is characterized by extensive telangiectasias and arteriovenous malformations. The primary clinical manifestation is epistaxis that results in ...

Posterior nasal packing and sphenopalatine artery ligation are substantially more invasive techniques, each associated with several serious potential complications, and are reserved for very severe ...

Certain intranasal corticosteroids (INCS) may place patients with allergic rhinitis at a higher risk for epistaxis, according to a study published in Otolaryngology-Head and Neck Surgery. Certain ...

Respiratory tract bleeding may be a marker of cancer. We quantified the risk of specific cancer types among patients with hospital-based diagnoses of epistaxis and haemoptysis relative to risk in the ...

Epistaxis, another term for internal nasal bleeding, can happen to anyone, no matter how old they are. It's a common but urgent issue, and a warning sign that there could be an underlying sickness.

Fatty liver disease - also known as non-alcoholic fatty liver disease - is the name for a range of liver conditions not caused by alcohol. The liver is responsible for more than 500 functions, meaning ...